Database of Knowledge Translation Tools Assessment Summary

Size: px
Start display at page:

Download "Database of Knowledge Translation Tools Assessment Summary"

Transcription

1 Database f Knwledge Translatin Tls Assessment Summary Mini-Balance Evaluatin Systems Test (Mini-BESTest) Summary Authrs: Anna Apelman, Marie Berg, Kjetil Bjerke, Elisabeth Trøyen Gundersen, Egil Hvland, Lene Kristiansen, Julia Mbalilaki, Jennifer Mre, Jan Nrdvik, Grethe Tveit Pettersen, Siri Slberg Date Published: December Instrument Descriptin and Administratin Instructins Purpse f the assessment: Multi-task balance assessment that identifies the fllwing pstural cntrl prblems: External perturbatins Anticipatry pstural adjustments Sensry rientatin Dynamic balance during gait Type f assessment: Perfrmance based, clinician rated measure Predicts fall risk, assesses balance impairment, measures change ver time Administratin instructins: Full testing instructins are lcated Patient perfrms 14 tasks Each task is rated n an rdinal scale f 0 t 2 Maximum scre is 28, minimum scre is 0 Standing n ne leg (item 3) and Cmpensatry stepping crrectin in lateral directin (item 6) were assessed n bth sides. The lwer scre f the tw shuld be used in the ttal scre calculatin. Standardizatin prcedures: Fllw the instructins n the testing frm. English standardizatin vides are available at: The Nrwegian translatin and standardizatin prcedures are available at: ICF Dmain: Bdy Functin Measurement Area: Balance Several articles cited in this summary were riginally extracted frm Di Carl et al, Cnsideratins fr Clinical Use Indicatins fr use: Can be used in many patient ppulatins as a measure t assess: balance impairment predict falls (with cautin) assess a patient s change in balance functin ver time Page 1 f 10

2 Cnsideratins: Has been tested in many patient ppulatins and perfrms cnsistently well acrss the diagnses The cut-ff fr fall risk is generally between 16 and 20, indicating patients wh scre less than this scre shuld be cnsidered at risk fr falls. Hwever, the sensitivity f the measure varies between 52% and 88%, indicating that it is crrectly identifying 52% 88% f fallers. Because sme fallers may be missed, it is imprtant t als use yur clinical judgment t determine fall risk when a patient scres abve the cut-ff scre. Pr reliability was nted n items 5 (cmpensatry stepping backward), 6 (cmpensatry stepping lateral), and 8 (fam eyes clsed), additinal standardizatin may be needed n these items (Tsang et al, 2013) During a pilt f the Mini-BESTest in practice in Nrway, many clinicians reprted discmfrt with administering the reactive pstural cntrl items (4, 5, 6; cmpensatry stepping frward, backward, lateral). Therefre, additinal training and experience with these items may be needed befre using the Mini-BESTest in rutine practice. The Knwledge Experts pilted the Mini-BESTest in clinical practice fr 6 mnths at 3 rehabilitatin facilities (n= 134). Sample: Parkinsn Disease (n=88), Strke (n=27), and ther diagnses (degenerative disease, plyneurpathy, ther neurlgic cnditins, and musculskeletal cnditins, n=19). Mean Admissin scres = 20.5 pints Mean discharge scre = 23.2 pints Mean change = 2.7 pints Mean time between test administratins = 2.75 weeks 62% demnstrated a meaningful change (scre change f > 3), including 44% f patients with Parkinsn disease and 63% f patients with strke A cmparisn with utcmes achieved in research studies in Parkinsn disease patients revealed that despite a shrt amunt f time between testing perids, changes seen were similar t thse seen in much lnger research studies. Fr example, in a study that cmpared intensive cycle ergmeter t treadmill fr 2, 30-minute sessins per day, 5 days per week, fr 3 weeks resulted in mean changes f 2.3 pints (ergmeter grup) and 3.3 pints (treadmill grup).(arclin, Pisan et al. 2015) A highly challenging balance prgram delivered in 60- minute sessins, 3 x week, fr 10 weeks resulted in a change f 3 pints.(cnradssn, Lfgren et al. 2015) These are just tw f many studies that tested patients with similar levels f balance impairment and achieved similar results with a much higher dse f therapy than in the Nrwegian clinics. Knwledge Expert grup recmmendatin: The Mini-BESTest can be used in inpatient and utpatient rehabilitatin t assess: Fall risk Change in balance ver time Administratin instructins: Fall risk: Administer nce, at any pint in patient s care when falls need t be assessed Change ver time: Need a minimum f 2 administratins t assess change ver time, but > 2 pints wuld be better when rehabilitatin episde is > 4 weeks. Within 2 days (r sessins) f admissin and discharge Fllw Nrwegian standardizatin (see clinical utility sectin) Apprpriate patients include: Page 2 f 10

3 Adult patients with neurlgic cnditins and lung disease; als apprpriate fr cmmunity dwelling lder adults Ambulatry patients (with r withut assistive device) Ptential facilitatrs Assessment results can mtivate patients, therefre it may help t educate patient n the reasn fr testing and the test results Dedicated equipment and testing area fr the Mini-BESTest Weekly reprting f results in team meetings If pssible, create a frm in the electrnic medical recrd fr dcumentatin See Mini-BESTest Implementatin package Sustainability strategies: Ensure clinicians understand hw t use the results t guide decisin-making Discuss test results ften with each ther, and when with patients (Fr example, the patient btained an 18 n the test, what interventins might be best?) Reprting f Mini-BESTest data in clinical practice Jurnal club n Mini-BEST studies Add Mini-BESTest r measurement educatin, training, and administratin as a part f the Medarbeidersamtale Clinical Utility Cst: Free Equipment required: standard height chair Number f items: 14 items Time t administer: 10 minutes 15 minutes Training required: Free training available in English available at: Nrwegian translatin and standardizatin prcedures are available at: 5. Interpretatin f the Results Standard Errr f Measurement (SEM): Chrnic Strke: 1.08 pints (Tsang et al, 2013) Mixed Neurlgic: 1.26 pints (Gdi et al, 2013) Older Cancer Survivrs:.86 pints (Huang et al, 2015) Cmmunity Dwelling Older Adults: 1.4 pints (Marques et al, 2016) Minimum Detectable Change (MDC): Chrnic Strke: MDC 95 = 3.0 pints (Tsang et al, 2013) Mixed Neurlgic: MDC 95 = 3.5 pints (Gdi et al, 2013) Parkinsn Disease: MDC 95 = 3.4 t 4.1 pints (Lfgren et al, 2014) Older Cancer Survivrs: Page 3 f 10

4 MDC 95 = 2.39 pints (Huang et al, 2015) Cmmunity Dwelling Older Adults: 3.8 pints r 16.3% (Marques et al, 2016) Minimal Clinical Imprtant Difference (MCID): Mixed Neurlgic: 4 pints (Gdi et al, 2013) Nrmative Values: Nt established Cut-ff scres: Elderly: < 16/28 indicates patient is at risk fr falling (Adequate area under the curve =.84; sensitivity 85%, specificity 75%; Yingyngyudha et al, 2015) <19.5 / 32 indicates patient is at risk fr falls (Adequate area under the curve =.76; sensitivity 74%; specificity 71%; psitive likelihd rati 2.49; negative likelihd rati.38; Marques et al, 2016) Parkinsn Disease: < 20/32 indicates patient is at risk fr falling (Adequate area under the curve =.86; sensitivity 88%, specificity 78%; Leddy et al, 2011) < 20/32 indicates patient is at risk fr falling ( Adequate area under the curve =.87; sensitivity 86%, specificity 78%; Duncan et al, 2012) < 16/32 indicates patient is at risk fr falling (Adequate area under the curve =.80; sensitivity 75%, specificity 79%; Duncan and Earhart et al, 2012) < 20/32 indicates patient is at risk fr falling (Adequate area under the curve =.77/.87; sensitivity 62%/82%, specificity 74%/78%; Duncan et al, 2013) < 19/32 indicates patient is at risk fr falling (Adequate area under the curve =.75; sensitivity 79%, specificity 67%; Mak and Auyeung et al, 2013) <19/28* indicates patient is at risk fr falling (Adequate area under the curve =.65, specificity 70 %, sensitivity 52 %; Schlenstedt et al, 2015; used riginal scring f 28) Strke: Chrnic Strke (Tsang et al, 2013): Limited assciatin between scre and fall histry Area under the curve =.64,.7 t.8 is acceptable), <17.5 indicates a patient is at risk fr falls (Area under the curve =.64; sensitivity 64%, specificity 64.2%; likelihd ratis were 1.8 and 1.6, respectively) Significantly smaller area under then curve than the Berg Balance Scale, but nt significantly different than the Timed Up and G, r One Leg Stance) Subacute Strke: Scre f > 9/28 indicates a patient has a high level f functinal ability (Area under the curve =.85; Chinsngkram et al, 2014) Multiple Sclersis (Rss et al, 2016): <19.5/28 indicates patient requires mbility aid (Adequate area under the curve =.88; LR+4.53; LR- 0.18) < 22.5/28 assciated with a histry f near falls (adequate area under the curve = 0.77; LR ; LR-= 0.19) Assciatin with histry f falls is pr (area under the curve = 0.65) 6. Applicatin t specific patient diagnses Ppulatins reviewed in this summary: Subacute strke, chrnic strke, mixed neurlgic ppulatins, Parkinsn Disease, Cancer survivrs, Knee Arthrplasty, Elderly, Multiple Sclersis Page 4 f 10

5 7. Psychmetric Prperties: Reliability: Test-Retest Reliability Parkinsn Disease: Excellent test-retest reliability (ICC =.92; Leddy et al, 2011) Excellent test-retest reliability (ICC =.98; Schlenstedt et al, 2015) Excellent inter-rater reliability (ICC =.80; Lfgren et al, 2014) Mixed Neurlgic: Excellent test-retest reliability (ICC =.96; Gdi et al, 2013) Older Cancer Survivrs: Excellent test-retest reliability (ICC =.90; Huang et al, 2015) Knee arthrplasty: Excellent test-retest reliability (ICC >.90; Chan and Pang, 2015) Cmmunity dwelling lder adults: Adequate test-retest reliability (ICC =.73) Inter-rater Reliability Chrnic Strke (Tsang et al, 2013): Excellent inter-rater reliability (ICC =.96, p <.001) When each item was analyzed fr reliability separately, adequate t excellent inter-rater reliability was nted fr each item EXCEPT items 5 (cmpensatry stepping backward), 6 (cmpensatry stepping lateral), and 8 (fam eyes clsed) Parkinsn Disease: Excellent inter-rater reliability (ICC =.91; Leddy et al, 2011 ) Excellent inter-rater reliability (ICC =.98; Schlenstedt et al, 2015) Adequate inter-rater reliability (ICC =.72; Lfgren et al, 2014) Mixed Neurlgic: Excellent inter-rater reliability (ICC =.98; Gdi et al, 2013) Older Cancer Survivrs: Excellent inter-rater reliability (ICC =.86; Huang et al, 2015) Knee arthrplasty: Excellent inter-rater reliability (ICC >.90; Chan and Pang, 2015) Cmmunity dwelling lder adults: Adequate inter-rater reliability (ICC =.71; Marques et al, 2016) Intra-rater Reliability Chrnic Strke: Excellent intra-rater reliability (ICC =.97, p <.001; Tsang et al, 2013) Internal Cnsistency Chrnic strke: Excellent internal cnsistency (Crnbach s alpha ranged frm.89 t.94 depending n rater; Tsang et al, 2013) Mixed Neurlgic: Excellent internal cnsistency (Crnbach s alpha =.90; Gdi et al, 2013) Knee arthrplasty: Excellent internal cnsistency (Crnbach s alpha >.95; Chan and Pang, 2015) Rasch Reliability Persn reliability Mixed Neurlgic Ppulatins (Franchignni et al, 2010): Excellent persn reliability (.86) Elderly and Parkinsn Disease (Maia et al, 2013): Excellent persn reliability (.91) Mixed Neurlgic Ppulatins (Franchignni et al, 2015): Excellent persn reliability (.91) Page 5 f 10

6 Persn separatin index Mixed Neurlgic Ppulatins (Franchignni et al, 2010): 2.5 Elderly and Parkinsn Disease (Maia et al, 2013): 3.16 Mixed Neurlgic Ppulatins (Franchignni et al, 2015): 3.24 Item reliability Mixed Neurlgic Ppulatins (Franchignni et al, 2010): Excellent item reliability (.98) Elderly and Parkinsn Disease (Maia et al, 2013): Excellent item reliability (.98) Mixed Neurlgic Ppulatins (Franchignni et al, 2015): Excellent item reliability (.99) Item separatin index Mixed Neurlgic Ppulatins (Franchignni et al, 2010): 7.4 Elderly and Parkinsn Disease (Maia et al, 2013): 6.41 Mixed Neurlgic Ppulatins (Franchignni et al, 2015): 1.2 Validity: Enter the results frm each type f validity study, if available. Include the actual validity cefficient and the descriptin f the strength f the statistics (excellent >.6; adequate is.31 t.59; pr <.30) Criterin Validity: Predictive Validity (see cut-ff scres abve) Cncurrent Validity: Parkinsn Disease: Excellent crrelatin with the BesTest (r =.96; Leddy et al, 2011) Excellent crrelatin with the Berg Balance Scale (r=.79; King et al, 2012) Excellent crrelatin with the Brief BesTest (r=.94; Duncan et al, 2013) Excellent crrelatin with the Berg Balance Scale (rh =.85; Schlenstedt et al, 2015) Excellent crrelatin with the Functinal Activity Balance Scale (rh =.87; Schlenstedt et al, 2015) Parkinsn Disease and Strke: Excellent crrelatin with the Berg Balance Scale (r=.94; Bergstrm et al, 2012) Mixed Neurlgical: Excellent crrelatin with the Berg Balance Scale (r=.85; Gdi et al, 2014) Subacute Strke: Excellent crrelatin with the BesTest (rh =.96; Chinsngkram et al, 2014) Chrnic Strke (Tsang et al, 2013): Excellent crrelatin with the BBS (rh=.83, p <.001) Adequate crrelatin with the Functin Reach Test (rh=.55, p <.001) Excellent crrelatin with ne leg standing n paretic side (rh=.83, p <.001) Adequate crrelatin with ne leg standing n the nnparetic side (rh =.54, p <.001) Excellent crrelatin with the Timed Up and G (rh=-.82, p <.001) Multiple Sclersis (Rss et al, 2016): Excellent crrelatin with the Berg Balance Scale (Rh =.788) Excellent crrelatin with MSIS-29 Phys (Rh =.643) Excellent crrelatin with MSWS-12 (Rh =.766) Excellent crrelatin with 6MWT (Rh =.810) Page 6 f 10

7 Adequate crrelatin with MFIS (Rh =.495) Adequate crrelatin with MSIS-29 Psyc (Rh =.390) Cmmunity Dwelling Older Adults: excellent crrelatin with the BBS, BESTest and Mini-BESTest (rh =.83 t.96; Marques et al, 2016) Cnstruct validity: Discriminant Validity Chrnic Strke: Pr crrelatin with the Mdified Ashwrth Scale (rh=-.22, p=.02; Tsang et al, 2013) Pr crrelatin with Abbreviated Mental Test (rh =.08, p=.42; Tsang et al, 2013) Pr crrelatin with the Geriatric Depressin Scale (rh=-.17, p=.08; Tsang et al, 2013) Cnvergent Validity: Parkinsn Disease: Excellent crrelatin with the Timed Up and G (r = -.81; Bergstrm et al, 2012) Adequate crrelatin with the Activities Specific Balance Cnfidence Scale (r=.53; Cmbs et al, 2014) Excellent crrelatin with the Timed Up and G (rh = -.76; Schlenstedt et al, 2015) Parkinsn Disease and Elderly: Excellent crrelatin with the Activities Specific Balance Cnfidence Scale (r =.66; McNeely et al, 2012) Parkinsn Disease and Strke: Pr crrelatin with the Falls Efficacy Scale (r = -.89; Bergstrm et al, 2012) Pr crrelatin with the Activities Specific Balance Cnfidence Scale (r =.26; Bergstrm et al, 2012) Chrnic Strke: Excellent crrelatin with the Timed Up and G (r = -.81; Bergstrm et al, 2012) Adequate crrelatin with the Chedke-McMaster Strke Assessment leg scre (rh=.53, p <.001; Tsang et al, 2013) Excellent crrelatin with the Chedke-McMaster Strke Assessment ft scre (rh=.64, p <.001; Tsang et al, 2013) Adequate crrelatin with Activities Specific Balance Cnfidence (rh=.50, p <.001; Tsang et al, 2013) Older Cancer Survivrs: Adequate crrelatin with the Activities Specific Balance Cnfidence Scale (rh =.52; Huang et al, 2015) Cmmunity Dwelling Older Adults: adequate crrelatin with the Activities Specific Balance Cnfidence (Rh =.61; Marques et al, 2016) Adults and elderly: Excellent crrelatin with the ne leg stance (r =.68; O Hlski et al, 2015) Excellent crrelatin with the Timed up and g (r = -.66; O Hlski et al, 2015) Excellent crrelatin with the Activities Specific Balance Cnfidence Scale (r =.62; O Hlski et al, 2015) COPD: Adequate crrelatin with the Mini-BesTest (r=.55; Jacme et al, 2016) Knwn grups validity: Chrnic Strke: Page 7 f 10

8 Significant difference between the strke and cntrl grups (median scre 19 vs. 27; p<.001; Tsang et al, 2013) Significant difference between fallers and nnfallers (median scre 16 vs. 19; p =.03; Tsang et al, 2013) Flr and ceiling effects: Chrnic Strke: Flr effects: Excellent, n flr effects (0%; Tsang et al, 2013) Ceiling effects: Excellent, minimal ceiling effects (.9%; Tsang et al, 2013) Subacute strke: Ceiling effects: excellent, minimal ceiling effects (4.3%; Chinsngkram et al, 2014) Flr effects: pr flr effects (34.3%; Chinsngkram et al, 2014) Flr effects: pr, flr effects befre rehab (32,7%; Chinsngkram et al, 2016) Adequate, flr effects in less than 20% f ppulatin after rehab (10,2%, Chinsngkram et al, 2016) Multiple Sclersis: Excellent, n ceiling effects (0%; Rss et al, 2016) Internal respnsiveness: The standardized respnse mean (SRM) was used t indicate the internal respnsiveness; large change >0.8, mderate change 0.5 > 0.8, small change < 0.2. SRM Imprvements in balance after rehabilitatin Subacute strke: Large effect (0,9 (0.6, 1,2): The BESTest shwed a significantly higher SRM than the Mini- BESTest (p<.001) Chinsngkram et al, 2016) Number f participants with n change 13 (26): The percentage f participants with n change was significantly higher with the Mini-BESTest cmpared t the BESTest (Chinsngkram et al, 2016) External respnsiveness: Area under the curve (AUC) > 0.9 Excellent Subacute strke: : Mini-BESTest 0.89 (0.79,0.99) (nt significantly different than the BESTest with an AUC f 0.92 Chinsngkram et al, 2016) The cut-ff scre fr the Mini-BESTest (> 3 pints) was clinically meaningful, LR (2.3, 19.8) and LR- 0.2 (0.1, 0.8) Chinsngkram et al, 2016) 8. Dcumentatin and Clinical Decisin-Making Tips: Cmpnents t include in dcumentatin: Assistive device used during the test 9. Links t ther relevant resurces: Websites: Online presentatins: Cpy f the instrument: Prvide a link t the instrument whenever it is available. 10. References and sample: Arclin, I., F. Pisan, C. Delcnte, M. Gdi, M. Schieppati, A. Mezzani, D. Picc, M. Grass and A. Nardne (2015). "Intensive cycle ergmeter training imprves gait speed and endurance in patients Page 8 f 10

9 with Parkinsn's disease: A cmparisn with treadmill training." Restr Neurl Neursci 34(1): Chan A & Pang M. Assessing Balance Functin in Patients With Ttal Knee Arthrplasty. Phys Ther. 2015; 95(10) Chinsngkram B, Chaikeeree N, Saengsirisuwan V, Viriyatharakij N, Hrak FB, & Bnsinsukh R. Reliability and validity f the Balance Evaluatin Systems Test (BESTest) in peple with subacute strke. Phys Ther. 2014; 94(11) Chinsngkram B, Chaikeeree N, Saengsirisuwan V, Hrak FB, and Bnsinsukh R. Respnsiveness f the Balance Evaluatin Systems Test (BESTest) in Peple with Subacute Strke. Am Phys Ther 2016, Vl 96 (x). Study sample: Subacute strke, mean age 57.8 (11.8), male/female 29/20, Time since strke 38,7 (36,7) days (range 2 120), Type f strke Ischemia 36, Hemrrhage 13, Affected side right 27, left 22, MMSE scre (/30) 28.4 (2.3), BI (/100) 49,8 (21.9), FM-Mtr scre (/100) 38 (27.4), Time between 2 assessments 13.7 (9,3) days. Cnradssn, D., N. Lfgren, H. Ner, M. Hagstrmer, A. Stahle, J. Lkk and E. Franzen (2015). "The Effects f Highly Challenging Balance Training in Elderly With Parkinsn's Disease: A Randmized Cntrlled Trial." Neurrehabil Neural Repair 29(9): Di Carl S, Bravini E, Vercelli S, Massazza G, & Ferrier G. The Mini-BESTest: a review f psychmetric prperties. Internatinal Jurnal f Rehabilitatin Research (in press) Study sample: Systematic review f all studies and ppulatins that assessed psychmetric prperties f the Mini-BesTest. Duncan R, Leddy A, Cavanaugh J, et al. Cmparative utility f the BESTest, mini-bestest, and brief-bestest fr predicting falls in individuals with Parkinsn disease: a chrt study. Phys Ther. 2013; 93(4) Franchignni F, Hrak F, Gdi M, Nardne A, Girdan A. Using psychmetric techniques t imprve the Balance Evaluatin Systems Test: the mini-bestest. J Rehabil Med. 2010; 42(4) Gdi M, Franchignni F, Caligari M, Girdan A, Turcat A, & Nardne A. Cmparisn f reliability, validity, and respnsiveness f the mini-bestest and Berg Balance Scale in patients with balance disrders. Phys Ther. 2013; 93(2) Leddy A, Crwner, B, & Earhart, G. Utility f the Mini-BESTest, BESTest, and BESTest sectins fr balance assessments in individuals with Parkinsn disease. J Neurl Phys Ther. 2011; 35(2)90-7. Lfgren N, Lenhlm E, Cnradssn D, Stahle A, & Franzen E. The Mini-BESTest--a clinically reprducible tl fr balance evaluatins in mild t mderate Parkinsn's disease? BMC Neurl (14) 235. Marques A, Almeida S, Carvalh J, Cruz J, Oliveira A, Jácme C. Balance tests in healthy lder peple Reliability, validity and ability t identify fall status f the BESTest, Mini-BESTest and Brief- BESTest in lder peple living in the cmmunity. Arch Phys Med Rehabil Dec;97(12): Page 9 f 10

10 Study sample: 122 lder adults, cmmunity dwelling, mean age yrs; 70.5% wmen; 13 participants used walking aids (11 used a cane, and 2 used a walker); average Mini-BESTest scre ; average BBS scre O'Hski S, Sibley K, Brks D, & Beauchamp M. Cnstruct validity f the BESTest, mini-bestest and briefbestest in adults aged 50 years and lder. Gait Psture. 2015;42(3): O'Hski S, Winship B, Herridge L, Agha T, Brks D, Beauchamp M, & Sibley K. Increasing the clinical utility f the BESTest, mini-bestest, and brief-bestest: nrmative values in Canadian adults wh are healthy and aged 50 years r lder. Phys Ther. 2014; 94(3): Rss E, purtill H, Uszynski M, Hayes S, Casey B, Brwne C, Cte S; Chrt study cmparing the Berg Balance Scale and the Mini Bestest in peple wh have multiple sclersis and are ambulatry. American Physical Therapy Assciatin 2016 Sep;96(9): Study Sample: Patients with Multiple Sclerris wh are ambulatry, with r withut a mbility aid, n= 52 (nne walking aid used =32(61,5%)), mean age 45,73, male/female 15/37,mean age since diagnsis 10,87. Schlenstedt C, Brmbacher S, Hartwigsen G, Weisser B, Mller B, & Deuschl G. Cmparisn f the Fullertn Advanced Balance Scale, Mini-BESTest, and Berg Balance Scale t Predict Falls in Parkinsn Disease. Phys Ther. 2016; 96(4) Study sample: Parkinsns disease, n=66 (fallers n=33, nn-fallers n=33). Mean age fallers 68.1 (7.5), mean age nn-fallers 66.0 (11.6). Fallers: male/female 20/13, nn-fallers: male/female 25/8. H&Y stage 1-4: fallers 2.5(0.8), nn-fallers 2.8 (0.7). Tested in the n-state f medicatin. Tsang CS, Lia LR, Chung R, & Pang M. Psychmetric prperties f the Mini-Balance Evaluatin Systems Test (Mini-BESTest) in Cmmunity-Dwelling Individuals with Chrnic Strke. Physical Therapy Jurnal. 2013;93: Study sample: Chrnic strke, mean age 57.1 (11.0), male/female 73/33, Pststrke duratin 2.9 years, hemiplegic side left (n=46) right (n=60), median Chedke McMaster Strke Assessment Scre Leg = 4, Ft = 3; Arm = 3; Hand = 3 Yingyngyudha A, Saengsirisuwan V, Panichaprn W, & Bnsinsukh, R. The Mini-Balance Evaluatin Systems Test (Mini-BESTest) Demnstrates Higher Accuracy in Identifying Older Adult Participants With Histry f Falls Than D the BESTest, Berg Balance Scale, r Timed Up and G Test. J Geriatr Phys Ther. 2016; 39(2): Arclin, I., F. Pisan, C. Delcnte, M. Gdi, M. Schieppati, A. Mezzani, D. Picc, M. Grass and A. Nardne (2015). "Intensive cycle ergmeter training imprves gait speed and endurance in patients with Parkinsn's disease: A cmparisn with treadmill training." Restr Neurl Neursci 34(1): Cnradssn, D., N. Lfgren, H. Ner, M. Hagstrmer, A. Stahle, J. Lkk and E. Franzen (2015). "The Effects f Highly Challenging Balance Training in Elderly With Parkinsn's Disease: A Randmized Cntrlled Trial." Neurrehabil Neural Repair 29(9): Page 10 f 10

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

Reliability and Validity Plan 2017

Reliability and Validity Plan 2017 Reliability and Validity Plan 2017 Frm CAEP The principles fr measures used in the CAEP accreditatin prcess include: (a) validity and reliability, (b) relevance, (c) verifiability, (d) representativeness,

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019

More information

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS 1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

2018 Medical Association Poster Symposium Guidelines

2018 Medical Association Poster Symposium Guidelines 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

The effects of a two-school. school-year. back education program. in elementary schoolchildren

The effects of a two-school. school-year. back education program. in elementary schoolchildren IEA Maastricht - 12 July 2006 The effects f a tw-schl schl-year multi-factrial back educatin prgram in elementary schlchildren Drs Elisabeth Geldhf Prf Dr D De Clercq Prf Dr I De Burdeaudhuij Prf Dr G

More information

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT INJECTIONS OR BLOCKS CPT Cdes: Cervical Thracic Regin: 64490 (+ 64491, +64492), 0213T (+0214T, +0215T) Lumbar Sacral Regin:

More information

The CPG and Who are We? Core Set Focus: Assess Change!

The CPG and Who are We? Core Set Focus: Assess Change! Implementing Cre Set f Outcme Measures fr Adults with Neurlgic Cnditins 1/24/2019 1 Implementing Cre Set f Outcme Measures fr Adults with Neurlgic Cnditins Thursday, January 24, 2019 8-10 Clinical Practice

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Evaluation of a Shared Decision Making Intervention between Patients and Providers to Improve Menopause Health Outcomes: Issue Brief

Evaluation of a Shared Decision Making Intervention between Patients and Providers to Improve Menopause Health Outcomes: Issue Brief Evaluatin f a Shared Decisin Making Interventin between Patients and Prviders t Imprve Menpause Health Outcmes: Issue Brief Key Findings Tablet technlgy can be successfully incrprated int primary practices

More information

LTCH QUALITY REPORTING PROGRAM

LTCH QUALITY REPORTING PROGRAM 4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04

More information

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management

More information

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...

More information

The principles of evidence-based medicine

The principles of evidence-based medicine The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t

More information

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre

More information

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH Aurra Health Care s Research Subject Prtectin Prgram (RSPP) This guidance dcument will utline the prper prcedures fr btaining and dcumenting

More information

Evaluation of Hunter & New England HealthPathways

Evaluation of Hunter & New England HealthPathways Evaluatin f Hunter & New England HealthPathways 2 General Practice & Ambulatry Care Activity General Practice MBS data: In 2013 there were 3.3 millin patient attendances t 730 GPs in the HML regin, a 5.6%

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO NIA Magellan 1 Spine Care Prgram Interventinal Pain Management Frequently Asked Questins (FAQs) Fr Medicare Advantage HMO and PPO Questin GENERAL Why is Flrida Blue implementing a Spine Management prgram

More information

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)

More information

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS INTRODUCTION This ntice prvides an verview f the parental special educatin rights, smetimes called prcedural safeguards

More information

COPD Outreach Program

COPD Outreach Program COPD Outreach Prgram Wendy Laframbise, Advanced Practice Nurse Certified Respiratry Educatr COPD Outreach Prgram March, 2015 Disclaimer: The Canadian Fundatin fr Healthcare Imprvement (CFHI), in partnership

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is

More information

Clinical Orthopaedic Rehabilitation Spinal Disorders

Clinical Orthopaedic Rehabilitation Spinal Disorders COURSE DESCRIPTION Clinical Orthpaedic Rehabilitatin Spinal Disrders This prgram is a practical, clinical guide that prvides guidance n the evaluatin, differential diagnsis, treatment and rehabilitatin

More information

Diabetes: HbA1c Poor Control (NQF 0059)

Diabetes: HbA1c Poor Control (NQF 0059) Diabetes: HbA1c Pr Cntrl (NQF 0059) EMeasure Name Diabetes: HbA1c Pr Cntrl EMeasure Id Pending Versin Number 1 Set Id Pending Available Date N infrmatin Measurement January 1, 20xx thrugh Perid December

More information

Cognitive enhancers for the treatment of Alzheimer s disease

Cognitive enhancers for the treatment of Alzheimer s disease Cmprehensive Research Plan: Cgnitive enhancers fr the treatment f Alzheimer s disease Pharmacepidemilgy Unit February 13 th, 2015 30 Bnd Street, Trnt ON, M5B 1W8 www.dprn.ca inf@dprn.ca 2 ODPRN Drug Class

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines

More information

FUNCTIONAL MOVEMENT SYSTEMS SCREEN FINDINGS REPORT

FUNCTIONAL MOVEMENT SYSTEMS SCREEN FINDINGS REPORT FUNCTIONA MOVEMENT SYSTEMS SCEEN FINDINGS EPOT Screening Date: Client: FMS Certified Member: FMS Scre: 09/0/1 04:15 PM Glenn D'Avanz Elizabeth Carus 17 Descriptin: FMS screen fr Glenn D'Avanz FUNCTIONA

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface MH-1 (NQF 0710): Depressin Remissin at Twelve Mnths Measure Steward: MNCM CMS Web Interface V2.1 Page 1 f 27 06/25/ Cntents INTRODUCTION... 4 CMS WEB INTERFACE SAMPLING INFORMATION...

More information

2019 Canada Winter Games Team NT Female Hockey Selection Camp August 16-19, 2018

2019 Canada Winter Games Team NT Female Hockey Selection Camp August 16-19, 2018 2019 Canada Winter Games Team NT Female Hckey Selectin Camp August 16-19, 2018 Strength and Cnditining Recmmendatins As discussed in the Call Fr Players letter, it is critical fr players t get their bdies

More information

A. Catalonia World Health Organization Demonstration Project

A. Catalonia World Health Organization Demonstration Project A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

PET FORM Planning and Evaluation Tracking ( Assessment Period)

PET FORM Planning and Evaluation Tracking ( Assessment Period) Divisin f: Behaviral Studies PET FORM Planning and Evaluatin Tracking (2010 2011 Assessment Perid) Persn Respnsible fr this Divisin: Jerry Mller Department f: Behaviral Sciences Persn Respnsible fr this

More information

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...

More information

Record of Revisions to Patient Tracking Spreadsheet Template

Record of Revisions to Patient Tracking Spreadsheet Template Recrd f Revisins t Patient Tracking Spreadsheet Template Belw is a recrd f revisins made by the AIMS Center t the Patient Tracking Spreadsheet Template. The purpse f this dcument is t infrm spreadsheet

More information

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit

More information

Medicare Advantage 2019 Advance Notice Part 1 21 st Century Cures Act Methodological Changes

Medicare Advantage 2019 Advance Notice Part 1 21 st Century Cures Act Methodological Changes Medicare Advantage 2019 Advance Ntice Part 1 21 st Century Cures Act Methdlgical Changes Review f Relevant Prvisins with Expert Insight January 2018 PULSE8 is privileged t bring yu a summary f key Medicare

More information

Sub-Topic: Massage for Depression, Anxiety, and Sleep Disorders Level 1 Knowledge: Attain and Comprehend Skills: Observe and Imitate

Sub-Topic: Massage for Depression, Anxiety, and Sleep Disorders Level 1 Knowledge: Attain and Comprehend Skills: Observe and Imitate Nte: Feedback frm prfessin stakehlders n the first draft f the Entry-Level Massage Educatin Blueprint indicated that this sub-tpic was beynd entry-level r unnecessary fr safe and cmpetent practice. The

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

Instructions regarding referral of patients to the Persistent Pain Service

Instructions regarding referral of patients to the Persistent Pain Service Prtsmuth Persistent Pain Service Lng Term Cnditins Suite Grund Flr, Blck A St Mary s Cmmunity Health Campus Miltn Rad Prtsmuth Hampshire PO3 6AD Tel: 23 9268 485 Fax: 23 9268 21 Dear GP Instructins regarding

More information

Neurological outcome from conservative or surgical treatment of cervical spinal cord injured patients

Neurological outcome from conservative or surgical treatment of cervical spinal cord injured patients 1993 nternatinal Medical Sciety f Paraplegia eurlgical utcme frm cnservative r surgical treatment f cervical spinal crd injured patients J E Kiwerski Spinal Department f Metrplitan Rehabilitatin Centre,

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface MH-1 (NQF 0710): Depressin Remissin at Twelve Mnths Measure Steward: MNCM CMS Web Interface V2.0 Page 1 f 27 11/13/2017 Cntents INTRODUCTION... 4 CMS WEB INTERFACE SAMPLING INFORMATION...

More information

Module 6: Goal Setting

Module 6: Goal Setting Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent

More information

9/22/2014. How to design clinical studies for physiotherapy in Parkinson s disease. Learning objectives. Key points

9/22/2014. How to design clinical studies for physiotherapy in Parkinson s disease. Learning objectives. Key points Hw t design clinical studies fr physitherapy in Parkinsn s disease Prf. Alice Nieuwber Department f Rehabilitatin Sciences University f Leuven, Belgium Learning bjectives Prvide an understanding f the

More information

Annual Assembly Abstract Review Process

Annual Assembly Abstract Review Process Annual Assembly Abstract Review Prcess AAHPM and HPNA cllabrate t review and select abstracts fr Annual Assembly. The cmmittees meet prir t the calls t review and update the Assembly bjectives (Planning

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

QUALITY AND SAFETY MEASURES UPDATE January 2016

QUALITY AND SAFETY MEASURES UPDATE January 2016 CLINICAL EFFECTIVENESS/SAFETY M CORE MEASURES 2015 See attached Results QUALITY AND SAFETY MEASURES UPDATE January 2016 Jint Cmmissin and CMS Cre Measure Dashbard updated with mst recent data available:

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synpsis This Clinical Study Synpsis is prvided fr patients and healthcare prfessinals t increase the transparency f Bayer's clinical research. This dcument is nt intended t replace the advice

More information

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070) Crnary Artery Disease (CAD): Beta Blcker Therapy fr CAD Patients with Prir Mycardial Infarctin (MI) (NQF 0070) EMeasure Name Crnary Artery Disease EMeasure Id Pending (CAD): Beta Blcker Therapy fr CAD

More information

Weight Assessment and Counseling for Children and Adolescents (NQF 0024)

Weight Assessment and Counseling for Children and Adolescents (NQF 0024) Weight Assessment and Cunseling fr Children and Adlescents (NQF 0024) EMeasure Name Weight Assessment and EMeasure Id Pending Cunseling fr Children and Adlescents Versin Number 1 Set Id Pending Available

More information

Guideline Number: NIA_CG_302 Last Revised Date: September 2015 Responsible Department: Implementation Date: September 2015 Clinical Operations

Guideline Number: NIA_CG_302 Last Revised Date: September 2015 Responsible Department: Implementation Date: September 2015 Clinical Operations Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT DENERVATION (RADIOFREQUENCY NEUROLYSIS) CPT Cdes: Cervical Thracic Regin: 64633, +64634 Lumbar Sacral Regin: 64635, +64636

More information

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

You may have a higher risk of bleeding if you take warfarin sodium tablets and: MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain

More information

Accounting Assessment Report

Accounting Assessment Report Accunting 2014-2015 Assessment Reprt 1. Please give a brief verview f the assessment data yu cllected this year. This can be in any frm yu feel is apprpriate, such as a table, a shrt narrative f results,

More information

Managing the Symptoms of Stroke

Managing the Symptoms of Stroke Unit 26: Recgnising and Managing the Symptms f Strke Unit reference number: F/616/7312 Level: 2 Unit type: Optinal Credit value: 3 Guided learning hurs: 28 Unit summary A strke can be a life-threatening

More information

Prostatitis - chronic - Management

Prostatitis - chronic - Management Prstatitis - chrnic - Management Scenari: Diagnsis f chrnic prstatitis Hw shuld I diagnse chrnic prstatitis? Diagnse chrnic prstatitis if: The man has pain in the perineum r pelvic flr and lwer urinary

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

WCPT awards programme 2015

WCPT awards programme 2015 WCPT awards prgramme 2015 The WCPT awards prgramme recgnises utstanding cntributins and leadership by individual physical therapists and grups t the prfessin and/r glbal health at an internatinal level.

More information

FDA Dietary Supplement cgmp

FDA Dietary Supplement cgmp FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Luisiana Healthcare Cnnectins Prviders Questin GENERAL Why did Luisiana Healthcare Cnnectins implement a Medical Prgram? Answer

More information

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals. 27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000

More information

Catherine Worthingham Fellows of APTA Instructions for Writing a Letter of Support

Catherine Worthingham Fellows of APTA Instructions for Writing a Letter of Support Catherine Wrthingham Fellws f APTA Instructins fr Writing a Letter f Supprt Fllwing is infrmatin designed t assist persns asked t write a letter f supprt fr a nminee fr the American Physical Therapy Assciatin

More information

For our protection, we require verification that you have received this notice. Therefore, please sign below.

For our protection, we require verification that you have received this notice. Therefore, please sign below. PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults

More information

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009 CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS) Questin GENERAL Why did MHS implement a Medical Specialty Slutins Prgram? Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Managed Health Services (MHS) Answer Effective Nvember

More information

Medication Assisted Treatment for Opioid Use Disorder in Rural Colorado

Medication Assisted Treatment for Opioid Use Disorder in Rural Colorado Medicatin Assisted Treatment fr Opiid Use Disrder in Rural Clrad Why is piid use disrder getting s much attentin? Opiid Use Disrder (OUD) has seen an epidemic rise in the United States ver the past decade.

More information

Implementation of Early retention monitoring of HIV positive pregnant and breastfeeding women; and data use in the EMTCT program MOH-UGANDA

Implementation of Early retention monitoring of HIV positive pregnant and breastfeeding women; and data use in the EMTCT program MOH-UGANDA Implementatin f Early retentin mnitring f HIV psitive pregnant and breastfeeding wmen; and data use in the EMTCT prgram MOH-UGANDA Presentatin utline Backgrund Methdlgy Issues addressed Challenges identified

More information

Database of Knowledge Translation Tools Intervention Summary

Database of Knowledge Translation Tools Intervention Summary Database f Knwledge Translatin Tls Interventin Summary 1. Mtivatinal Interviewing (MI) t Increase Physical Activity in Peple with Chrnic Health Cnditins Summary Authr: Egil Hvland, PT Date Published: Pending

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential

More information

For our protection, we require verification that you have received this notice. Therefore, please sign below.

For our protection, we require verification that you have received this notice. Therefore, please sign below. PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults

More information

The Texas Medication Algorithm Project: Clinical Results for Schizophrenia

The Texas Medication Algorithm Project: Clinical Results for Schizophrenia The Texas Medicatin Algrithm Prject: Clinical Results fr Schizphrenia by Alexander L. Miller, M. Lynn Crismn, A. Jhn Rush, Jhn Chiles, T. Michael Kashner, Marcia Tprac, Thmas Carmdy, Melanie Biggs, Kathy

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

Pain Management Learning Plan

Pain Management Learning Plan Pain Management Learning Plan Overriding Gal T imprve the quality f patient care available fr patients living with chrnic pain. Learning Outcmes By the end f the implementatin, participants will be able

More information

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information

Access to Heme Treatment in Canada - Survey 2018

Access to Heme Treatment in Canada - Survey 2018 Access t Heme Treatment in Canada - Survey 2018 The Canadian Assciatin fr Prphyria/Assciatin Canadienne de Prphyrie (CAP/ACP) asserts that patients with acute prphyria shuld have access t Hemin treatment,

More information

Lumbar Spondylolysis/listhesis Rehabilitation Guideline

Lumbar Spondylolysis/listhesis Rehabilitation Guideline Lumbar Spndyllysis/listhesis Rehabilitatin Guideline This rehabilitatin prgram is designed t return the individual t their activities as quickly and safely as pssible. It is designed fr rehabilitatin fllwing

More information

Sensorimotor Changes Following Distal Radius Fractures: Clinical Significance

Sensorimotor Changes Following Distal Radius Fractures: Clinical Significance Sensrimtr Changes Fllwing Distal Radius Fractures: Clinical Significance Christs Karagiannpuls MPT, M.Ed, ATC, CHT, Ph.D ATI Physical Therapy OrthpaediCare Center 1200 Manr Drive, Chalfnt, PA 18914 Distal

More information

Pain relief after surgery

Pain relief after surgery Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read

More information

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will: Nutritin Care Prcess Mdel Tutrials Nutritin Care Prcess and Terminlgy Cmmittee Academy f Nutritin and Dietetics Nutritin Care Prcess Terminlgy 2015 Editin Nutritin Mnitring & Evaluatin: Overview & Definitin

More information

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10 Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

Occupational Therapy Services AHM

Occupational Therapy Services AHM Occupatinal Therapy Services AHM Clinical Indicatins Occupatinal Therapy in an utpatient setting is cnsidered medically necessary when ALL f the fllwing Physician has rdered ccupatinal therapy and dcumentatin

More information

Effective date: 15 th January 2017 Review date: 1 st May 2017

Effective date: 15 th January 2017 Review date: 1 st May 2017 Title: Standard Operating Prcedures (SOP) fr Rutine Registry Operatins- Implementatin, Establishment and Maintenance f Mther & Child Health (MCH) Registry Sub-title: Training and User Supprt Effective

More information